{"id":"W2949656920","doi":"10.1016/j.jtcvs.2019.03.134","title":"A LEADER in the management of type 2 diabetes and cardiorenal disease","year":2019,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Ethicon; Janssen Biotech; Idorsia Pharmaceuticals; Eisai; Novo Nordisk; Daiichi-Sankyo; AstraZeneca; Amarin Corporation; Valeant Pharmaceuticals International; Ironwood Pharmaceuticals, Incorporated; Medtronic; Bayer HealthCare; Sanofi; Roche; Novartis; St. Jude Medical; Chiesi España; Merck; GlaxoSmithKline; Servier; Bayer; Chiesi Farmaceutici; Forest Laboratories; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Cardiorenal syndrome; Type 2 diabetes; Diabetes mellitus; Disease; Intensive care medicine; Disease management; Cardiology; Internal medicine; Kidney disease; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002607976,0.0006869717,0.001095776,0.0008230445,0.004355282,0.003873545,0.001032196,0.02618602,0.007173492],"category_scores_gemma":[0.02197296,0.0005551237,0.0008197606,0.0005625421,0.002151837,0.005349027,0.001875936,0.04148791,0.003300817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002787608,"about_ca_system_score_gemma":0.004787859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00281674,"about_ca_topic_score_gemma":0.005004684,"domain_scores_codex":[0.9960684,0.001418979,0.0004209005,0.0004034967,0.00115193,0.0005363112],"domain_scores_gemma":[0.9888229,0.00314627,0.0007722615,0.0002274716,0.00229535,0.004735816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004718384,0.00009605458,0.002714985,0.00008957507,0.00002275078,0.009704167,0.0003212246,0.000116586,0.0002007383,0.003338947,0.9701647,0.01318318],"study_design_scores_gemma":[0.0002296493,0.0002315339,0.00397923,0.001732152,0.00005866843,0.03339326,0.002514821,0.001111023,0.0002340358,0.01363748,0.9427362,0.0001419427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0004991785,0.001672142,0.0001462819,0.9721488,0.02285727,0.000006647163,0.0000115471,0.00001100728,0.002647151],"genre_scores_gemma":[0.01243462,0.004203036,0.0008957237,0.846034,0.1248824,0.00004335507,0.00002163971,0.00003107485,0.01145416],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02618602,"threshold_uncertainty_score":0.02399766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.021675836846124,"score_gpt":0.2559574588093977,"score_spread":0.2342816219632737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}